obesity-995x60.png
FEATURED ARTICLES
The Art And Skill Of Caring For Terminally Ill Patients In Clinical Research And Beyond
When designing and conducting trials for terminally ill patients, Kamila Novak reminds researchers to act and speak with respect, warmth, and thoughtfulness.
-
What The FDA's Psychedelic Drug Focus Means For Classic Psychedelic Development
Complementing an interview with Enveric Bioscience's Joseph Tucker, Ph.D., this Q&A explores Josh Hardman's thoughts on what FDA’s psychedelic focus could mean for classic psychedelic development.
-
5 Signs Your Clinical Trial Needs Outside Help
Could you use some outside help? The right outside partner can bring the expertise, capacity, and perspective needed to get studies back on track.
-
How FDA Alignment Is Shaping Opus Genetics' OPGx-LCA5 Development Strategy
Opus Genetics shares how FDA alignment yielded a clearer path for its ultra-rare LCA5 gene therapy, shaping trial design, evidence generation, and operations.